Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.4K
Neural Regulation01:37

Neural Regulation

42.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

793
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
793

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>GCH1</i> p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations.

medRxiv : the preprint server for health sciences·2026
Same author

Transcriptome analysis in osteoarthritis primary tissues identifies high-confidence effector genes.

Nature communications·2026
Same author

Comparison of Proteomic Analysis of Cerebrospinal Fluid From Neurological Patients With and Without Amyotrophic Lateral Sclerosis.

Journal of neurochemistry·2026
Same author

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

NPJ Parkinson's disease·2026
Same author

Longitudinal Repeatome Remodeling in Peripheral Blood Following Parkinson's Disease Diagnosis.

Genes·2026
Same author

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

NPJ Parkinson's disease·2026

Related Experiment Video

Updated: Dec 2, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.9K

Transcriptomic profiles in Parkinson's disease.

Lille Kurvits1,2, Freddy Lättekivi3, Ene Reimann4

  • 1Department of Neurology and Neurosurgery, University of Tartu, Tartu 50406, Estonia.

Experimental Biology and Medicine (Maywood, N.J.)
|November 5, 2020
PubMed
Summary
This summary is machine-generated.

Parkinson's disease transcriptomics reveals limited overlap in gene expression between blood, skin, and brain tissues. Despite this, peripheral tissues show potential disease-specific changes, suggesting Parkinson's may be a multisystem disorder.

Keywords:
Biomarkersbloodbrainneurodegenerationskintranscriptomics

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.8K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human &#945;-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.3K

Related Experiment Videos

Last Updated: Dec 2, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.8K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human &#945;-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Transcriptomics aids Parkinson's disease (PD) research but brain tissue access is limited.
  • Peripheral tissues like blood and skin offer alternative sources for PD molecular profiling.

Purpose of the Study:

  • To profile and compare gene expression in blood and skin of PD patients versus controls.
  • To meta-analyze existing transcriptomic data from PD brain and blood samples.
  • To investigate PD as a potential multisystem disorder by examining peripheral tissues.

Main Methods:

  • RNA-sequencing and RT-qPCR were used for blood and skin samples from 12 PD patients and 12 controls.
  • Robust rank aggregation (RRA) method was applied for meta-analysis of previous PD transcriptomic data.
  • Comparison of gene expression profiles across blood, skin, and post-mortem brain tissues.

Main Results:

  • No overlapping differentially expressed genes or pathways were found between blood and skin in the current study.
  • Meta-analysis identified significant gene expression changes in cortex, substantia nigra, and blood.
  • Minimal overlap was observed between gene expression changes in different tissues, including skin and cortex.

Conclusions:

  • Parkinson's disease shows limited shared transcriptomic signals across blood, skin, and brain tissues.
  • Divergent gene expression profiles and transcriptomic noise may obscure common signals.
  • Peripheral tissues exhibit potential PD-specific alterations, supporting the hypothesis of Parkinson's as a multisystem disorder.